Steady-state pharmacokinetics, of tramadol HCl extended-release tablets in patients with mild and moderate renal failure

被引：0
|
作者：
Lai, John Chi-Keung
Sista, Suryanarayana
Eradiri, Okponanabofa
Danyluk, Alexander
Brett, Vincent
机构：
[1] Biovail Technol Ltd, Dept Pharmacokinet & Toxicol, Chantilly, VA USA
[2] Ortho Mcneil Janssen Sci Affairs, Dept Med Commun, Raritan, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 46卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
129
引用
收藏
页码：1092 / 1092
页数：1
相关论文
共 50 条
  • [41] A COMPARATIVE-STUDY OF THE STEADY-STATE PHARMACOKINETICS OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE DILTIAZEM TABLETS
    LEEUWENKAMP, OR
    VISSCHER, HW
    MENSINK, CK
    JONKMAN, JHG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (03) : 243 - 247
  • [42] Quality-of-life outcomes of tramadol HCl extended-release tablet (ULTRAM® ER) in patients with osteoarthritis.
    Janagap, Carmela
    Schein, Jeff
    Kosinski, Mark
    Vorsanger, Gary
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S671 - S671
  • [43] Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers
    Akwete Adjei
    Robert J. Kupper
    Nathan S. Teuscher
    Sharon Wigal
    Floyd Sallee
    Ann Childress
    Scott H. Kollins
    Laurence Greenhill
    Clinical Drug Investigation, 2014, 34 : 795 - 805
  • [44] Steady-State Bioavailability of Extended-Release Methylphenidate (MPH-MLR) Capsule vs. Immediate-Release Methylphenidate Tablets in Healthy Adult Volunteers
    Adjei, Akwete
    Kupper, Robert J.
    Teuscher, Nathan S.
    Wigal, Sharon
    Sallee, Floyd
    Childress, Ann
    Kollins, Scott H.
    Greenhill, Laurence
    CLINICAL DRUG INVESTIGATION, 2014, 34 (11) : 795 - 805
  • [45] Steady-state rofecoxib pharmacokinetics (PK) in moderate hepatic insufficiency patients (HI).
    Schwartz, JI
    Larson, PJ
    Gertz, BJ
    Cote, J
    Lasseter, K
    Porras, AG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P60 - P60
  • [46] STEADY-STATE BUCINDOLOL PHARMACOKINETICS IN PATIENTS WITH MODERATE TO SEVERE ESSENTIAL-HYPERTENSION
    ROCCI, ML
    HARRIS, HH
    RILEY, LJ
    SAVITZKY, CW
    FRUNCILLO, RJ
    SOYKA, L
    FERGUSON, RK
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 453 - 453
  • [47] Steady-state Pharmacokinetics of Nevirapine Extended-release Tablets in HIV-1-infected Children and Adolescents An Open-label, Multiple-dose, Cross-over Study
    Giaquinto, Carlo
    Anabwani, Gabriel
    Feiterna-Sperling, Cornelia
    Nuttall, James
    Mompati, Kgosidialwa
    Koenigs, Christoph
    Mensa, Federico J.
    Sabo, John P.
    Yong, Chan-Loi
    MacGregor, Thomas R.
    Thuy Nguyen
    Quinson, Anne-Marie
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (07) : E173 - E179
  • [48] Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients
    Budde, K
    Neumayer, HH
    Lehne, G
    Winkler, M
    Hauser, IA
    Lison, A
    Fritsche, L
    Soulillou, JP
    Fauchald, P
    Dantal, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (10) : 2606 - 2614
  • [49] A controlled, randomized evaluation of the steady state pharmacokinetics of Carbatrol® extended-release capsules and Tegretol-XR®
    Stevens, RE
    Limsaken, T
    Evans, G
    Mason, DH
    NEUROLOGY, 1998, 50 (04) : A100 - A100
  • [50] Comparison of antihypertensive efficacy and tolerability of losartan and extended-release felodipine in patients with mild to moderate hypertension
    Hung, MJ
    Lin, FC
    Cherng, WJ
    Wang, CH
    Hung, KC
    Hsieh, IC
    Wen, MS
    Wu, DL
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (06) : 403 - 409
12345